Status:
COMPLETED
A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.
Lead Sponsor:
Pfizer
Conditions:
Hyperlipidemia
Dyslipidemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The Torcetrapib project was terminated on December 2, 2006 due to safety findings. Cholesterol levels will be measured over six weeks in subjects being treated with two different kinds of cholesterol...
Detailed Description
For additional information please call: 1-800-718-1021
Eligibility Criteria
Inclusion
- eligible for statin treatment for LDL cholesterol by NCEP guidelines
Exclusion
- Women who are pregnant or lactating, or planning to become pregnant.
- Subjects taking any drugs known to be associated with an increased risk of myositis in combination with HMG-CoA reductase inhibitors.
- Subjects with significant liver or kidney disease or significant heart failure.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
640 Patients enrolled
Trial Details
Trial ID
NCT00267254
Start Date
January 1 2006
End Date
August 1 2006
Last Update
November 21 2007
Active Locations (49)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Birmingham, Alabama, United States
2
Pfizer Investigational Site
Mobile, Alabama, United States
3
Pfizer Investigational Site
Mesa, Arizona, United States
4
Pfizer Investigational Site
Phoenix, Arizona, United States